Loading insider details...
Beta
Latest Form 4 (Aug 5, 2026): Disposition to Issuer of 11 GRTX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 5, 2026 | Galera Therapeutics, Inc. (GRTX) | Disposition to Issuer | 11 | n/a |
| Jun 5, 2026 | BRIGHT HORIZONS FAMILY SOLUTIONS INC. (BFAM) | Grant/Award | 2,096 | n/a |
| Jan 6, 2026 | Mersana Therapeutics, Inc. (MRSN) | Tender of Shares | 578 | n/a |
| Jun 13, 2025 | Mersana Therapeutics, Inc. (MRSN) | Grant/Award | 61,500 | n/a |
| Jun 5, 2025 | BRIGHT HORIZONS FAMILY SOLUTIONS INC. (BFAM) | Grant/Award | 976 | n/a |
| Feb 26, 2025 | Galera Therapeutics, Inc. (GRTX) | Grant/Award | 48,000 | n/a |
| Jan 3, 2025 | Mersana Therapeutics, Inc. (MRSN) | Grant/Award | 12,521 | n/a |
| Oct 3, 2024 | Mersana Therapeutics, Inc. (MRSN) | Grant/Award | 9,615 | n/a |
| Jul 2, 2024 | Mersana Therapeutics, Inc. (MRSN) | Grant/Award | 8,972 | n/a |
| Jul 1, 2024 | Adaptimmune Therapeutics PLC (ADAP) | Grant/Award | 1,213,926 | n/a |